Overview
Portfolio
More
Quadrascope
Boston, United States
Focus on early‑stage healthcare companies developing pharmaceuticals, diagnostics, software, equipment and devices to enable biological age reversal and disease prevention.
Portfolio
3+
Employees
5+
Founded
2022
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Quadrascope
Focus on early‑stage healthcare companies developing pharmaceuticals, diagnostics, software, equipment and devices to enable biological age reversal and disease prevention.
Portfolio
3+
Employees
5+
Founded
2022
AUM
N/A
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Showing 2 of 2 matched portfolio companies
The startup develops injectable scaffolds and foams that mimic the extracellular matrix to promote tissue repair and remodeling at the injection site. Their products provide healthcare professionals with effective tools to enhance the body's natural healing processes in various medical applications.
Funding: $3.0M
Rough estimate of the amount of funding raised
Funding: $3.0M
Rough estimate of the amount of funding raised
Immunis is a biotechnology company developing IMM01-STEM, a biologic therapy that utilizes natural human immune modulators to enhance muscle regeneration and metabolism. The company is conducting a Phase 1/2a clinical trial to evaluate the therapy's effectiveness in treating age-related muscle atrophy.
Funding: $37.0M
Rough estimate of the amount of funding raised
Funding: $37.0M
Rough estimate of the amount of funding raised
Showing 1 of 1 unmatched portfolio company